Health Care: Drugs

Celgene Corp (CELG: NASDAQ)

$107.52 n/a | n/a%
07/22/16 - 04:00 PM ET
Latest Dividend:0
Latest Dividend Yield:0%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:51.9082
Price Earnings Comparisons:
CELGSector Avg.S&P 500
51.908252.112.9
Price Performance History (% change):
3 Mo1 Yr3 Yr
-2.7144-22.233555.7358
GROWTH12 Mo3 YrCAGR
Revenue20.70.70.19
Net Income-19.90.10.03
EPS-18.80.20.06
Earnings for CELG:
EBITDA2.96B
REVENUE9.26B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $1.25 $1.32 $5.06 $6.34
Number of Analysts 3 3 3 3
High Estimate $1.26 $1.36 $5.11 $6.38
Low Estimate $1.24 $1.29 $5.01 $6.29
Prior Year $1.08 $1.12 $4.08 $5.06
Growth Rate (Year over Year) 15.74% 18.15% 24.02% 25.23%

Portfolios with CELG

Latest CELG Headlines from TheStreet

More Financial News for CELG

Press Releases for CELG

See All Press Releases

Partner Headlines for CELG

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter